deltatrials
Terminated NA INTERVENTIONAL 1-arm NCT00442494

Corticosteroids for the Prevention of Atrial Fibrillation After Cardiac Surgery

Feasibility of Corticosteroid in the Prevention of Atrial Fibrillation After Cardiac Surgery: A Prospective, Double-Blind Randomized Multicenter Trial

Sponsor: Kuopio University Hospital

Updated 5 times since 2017 Last updated: Nov 15, 2012 Started: Oct 31, 2012 Primary completion: Oct 31, 2012 Completion: Oct 31, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study has been completed as planned

This NA trial investigates Atrial Fibrillation and is currently terminated or withdrawn. Kuopio University Hospital leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated NA

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated NA

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated NA

    First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Kuopio University Hospital
  • Oulu University Hospital
  • Tampere University Hospital
Data source: Kuopio University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.